Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation
- 1 October 2021
- journal article
- letter
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (10), 1489-1490
- https://doi.org/10.7326/l21-0562
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial FibrillationAnnals of Internal Medicine, 2021
- Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral ValveThe New England Journal of Medicine, 2020
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial FibrillationJournal of Invasive Cardiology, 2019
- 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillationHeart Rhythm, 2019
- Dabigatran versus Warfarin in Patients with Mechanical Heart ValvesThe New England Journal of Medicine, 2013
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012